PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

93 hedge funds and large institutions have $129M invested in Palvella Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 34 reducing their positions, and 12 closing their positions.

Holders
93
Holders Change
+1
Holders Change %
+1.09%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
24
Reduced
34
Closed
12
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$5.7M
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$3.01M
3
ACM
3
Aquilo Capital Management
California
$6.82M
4
OAM
4
Oxford Asset Management
United Kingdom
$2.11M
5
FI
5
Fosun International
China
$1.62M

Top Sellers

1
TCM
1
Tekla Capital Management
Massachusetts
$6.81M
2
WCM
2
Wedge Capital Management
North Carolina
$0
3
Arrowstreet Capital
3
Arrowstreet Capital
Massachusetts
$0
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$0
5
Bank of America
5
Bank of America
North Carolina
$206K
Name Market Value Shares Shares
Change 		Shares
Change %
Two Sigma Investments
101
Two Sigma Investments
New York
– – -364 Closed
Man Group
102
Man Group
United Kingdom
– – -190 Closed
CS
103
Credit Suisse
Switzerland
– – -159 Closed
CHP
104
Cable Hill Partners
Oregon
– – -88 Closed
RBC
105
Roble Belko & Company
Pennsylvania
– – -26 Closed
CFGS
106
Concourse Financial Group Securities
Alabama
– – – –
1 2 3 4
5